Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Farmers Insurance
Federal Trade Commission
Colorcon
McKesson
QuintilesIMS
McKinsey
Queensland Health
Argus Health

Generated: September 19, 2018

DrugPatentWatch Database Preview

CISATRACURIUM BESYLATE PRESERVATIVE FREE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Cisatracurium Besylate Preservative Free, and what generic alternatives are available?

Cisatracurium Besylate Preservative Free is a drug marketed by Accord Hlthcare, Fresenius Kabi Usa, Jiangsu Hengrui Med, and Sandoz Inc. and is included in four NDAs.

The generic ingredient in CISATRACURIUM BESYLATE PRESERVATIVE FREE is cisatracurium besylate. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cisatracurium besylate profile page.

Summary for CISATRACURIUM BESYLATE PRESERVATIVE FREE
Drug patent expirations by year for CISATRACURIUM BESYLATE PRESERVATIVE FREE
Pharmacology for CISATRACURIUM BESYLATE PRESERVATIVE FREE

US Patents and Regulatory Information for CISATRACURIUM BESYLATE PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 205872-001 Jun 16, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz Inc CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 200154-001 Feb 3, 2012 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 203182-002 Feb 26, 2015 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz Inc CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 200154-002 Feb 3, 2012 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Accord Hlthcare CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 205872-002 Jun 16, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa CISATRACURIUM BESYLATE PRESERVATIVE FREE cisatracurium besylate INJECTABLE;INJECTION 203182-001 Feb 26, 2015 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Farmers Insurance
Federal Trade Commission
Colorcon
McKesson
QuintilesIMS
McKinsey
Queensland Health
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.